 |
114 Diseases |  |
151 Trials |
|
151 Trials |  |
5480 News |  |
| «12...156157158159160161162163164165166...167168» |
- | bortezomib / Generic mfg., cyclophosphamide / Generic mfg., doxycycline / Generic mfg.
New trial: BCD With or Without Doxycycline in Mayo Stage II-III Light Chain Amyloidosis Patients (clinicaltrials.gov) - Jan 16, 2018
P=N/A, N=140, Not yet recruiting, Sponsor: Jian Li
- ||| doxycycline / Generic mfg., ivermectin topical / Generic mfg.
Enrollment closed, Trial primary completion date: ANSWER: Oracea Soolantra Association in Participants With Severe Rosacea (clinicaltrials.gov) - Jan 12, 2018
P4, N=270, Active, not recruiting, Sponsor: Galderma
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> Feb 2018
- | doxycycline / Generic mfg.
New P2 trial: Doxycycline for Hereditary Hemorrhagic Telangiectasia (clinicaltrials.gov) - Jan 12, 2018
P2, N=30, Not yet recruiting, Sponsor: St. Michael's Hospital, Toronto
- | doxycycline / Generic mfg.
Enrollment closed, Enrollment change, Trial initiation date, Trial primary completion date: Doxycycline for COPD in HIV-Infected Patients (clinicaltrials.gov) - Jan 10, 2018
P=N/A, N=61, Active, not recruiting, Sponsor: Weill Medical College of Cornell University
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> Feb 2018 Recruiting --> Active, not recruiting | N=30 --> 61 | Initiation date: Jan 2014 --> Jul 2014 | Trial primary completion date: Jun 2017 --> Oct 2017
- | Trial completion, Enrollment change: Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) (clinicaltrials.gov) - Jan 9, 2018
P2, N=29, Completed, Sponsor: Johns Hopkins University
Recruiting --> Active, not recruiting | N=30 --> 61 | Initiation date: Jan 2014 --> Jul 2014 | Trial primary completion date: Jun 2017 --> Oct 2017 Active, not recruiting --> Completed | N=40 --> 29
- | nitazoxanide / Generic mfg.
Trial primary completion date: A Two Week Nitazoxanidebased Quadruple Regimen (clinicaltrials.gov) - Jan 3, 2018
P3, N=100, Recruiting, Sponsor: Tanta University
Active, not recruiting --> Completed | N=40 --> 29 Trial primary completion date: Dec 2017 --> Dec 2022
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion, Enrollment change: Lipids of the Human Tear Film and Their Effect on Tear Stability (clinicaltrials.gov) - Dec 22, 2017
P4, N=31, Completed, Sponsor: University of Louisville
Trial primary completion date: Dec 2017 --> Dec 2022 Recruiting --> Completed | N=400 --> 31
- | Sivextro (tedizolid) / Merck (MSD), Nabriva Therap
New trial: TEDIZOAM: Tedizolid Prolonged Treatment for Prosthetic Joint Infections (clinicaltrials.gov) - Dec 20, 2017
P=N/A, N=35, Not yet recruiting, Sponsor: Tourcoing Hospital
- | spironolactone / Generic mfg.
Enrollment open: FASCE: Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman. (clinicaltrials.gov) - Dec 18, 2017
P3, N=200, Recruiting, Sponsor: Nantes University Hospital
Recruiting --> Completed | N=400 --> 31 Not yet recruiting --> Recruiting
- | doxycycline / Generic mfg., azithromycin / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date: START: Scrub Typhus Antibiotic Resistance Trial (clinicaltrials.gov) - Dec 14, 2017
P4, N=177, Recruiting, Sponsor: University of Oxford
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Initiation date: May 2017 --> Oct 2017 | Trial primary completion date: May 2019 --> Oct 2019
- | doxycycline / Generic mfg., Pierre Fabre, minocycline extended release / Generic mfg.
Journal: Influence of Market Competition on Tetracycline Pricing and Impact of Price Increases on Clinician Prescribing Behavior. (Pubmed Central) - Dec 6, 2017
This dramatic increase in the cost of doxycycline hyclate is not easily explained using the framework of a competitive market, suggesting non-competitive market forces may be responsible. In addition, clinicians have not altered their prescribing behavior in response to this price increase, suggesting that clinician or pharmacy level interventions could potentially increase utilization of less costly substitutes.
- | doxycycline / Generic mfg., azithromycin / Generic mfg.
Trial initiation date, Trial primary completion date: Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction (clinicaltrials.gov) - Dec 5, 2017
P4, N=40, Not yet recruiting, Sponsor: Medical University of Vienna
In addition, clinicians have not altered their prescribing behavior in response to this price increase, suggesting that clinician or pharmacy level interventions could potentially increase utilization of less costly substitutes. Initiation date: Jun 2017 --> Jan 2018 | Trial primary completion date: Jul 2018 --> Jul 2019
- | doxycycline / Generic mfg.
Trial completion, Trial primary completion date, IO biomarker: Doxycycline in Human Pulmonary Tuberculosis (clinicaltrials.gov) - Nov 27, 2017
P2, N=40, Completed, Sponsor: National University Hospital, Singapore
Initiation date: Jun 2017 --> Jan 2018 | Trial primary completion date: Jul 2018 --> Jul 2019 Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jun 2017
- ||||| ilaprazole / Generic mfg., doxycycline / Generic mfg.
New P4 trial: The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers (clinicaltrials.gov) - Nov 17, 2017
P4, N=240, Not yet recruiting, Sponsor: The Third Xiangya Hospital of Central South University
- ||||| minocycline modified release (DFD-29) / Fortress
New P2 trial: A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules (clinicaltrials.gov) - Nov 14, 2017
P2, N=200, Recruiting, Sponsor: Dr. Reddy's Laboratories Limited
- | doxycycline / Generic mfg.
Enrollment open: Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma (clinicaltrials.gov) - Nov 14, 2017
P2, N=20, Recruiting, Sponsor: Rochester General Hospital
Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jun 2017 Not yet recruiting --> Recruiting
- | doxycycline / Generic mfg.
New trial: Duration of Doxycycline Treatment in MEM Patients (clinicaltrials.gov) - Nov 9, 2017
P=N/A, N=200, Not yet recruiting, Sponsor: University Medical Centre Ljubljana
- | spironolactone / Generic mfg.
New P3 trial: FASCE: Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman. (clinicaltrials.gov) - Nov 7, 2017
P3, N=200, Not yet recruiting, Sponsor: Nantes University Hospital
- |||| doxycycline / Generic mfg.
Trial completion: A Treatment for Severe Inflammatory Acne Subjects (clinicaltrials.gov) - Nov 1, 2017
P4, N=186, Completed, Sponsor: Galderma Laboratories, L.P.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | doxycycline / Generic mfg.
Trial primary completion date: KL2TR001438: Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial (clinicaltrials.gov) - Oct 27, 2017
P2, N=31, Recruiting, Sponsor: Medical College of Wisconsin
Active, not recruiting --> Completed Trial primary completion date: Sep 2017 --> Sep 2018
- | doxycycline / Generic mfg.
New trial: Fistulodesis Pilot Study for Closure of Perianal Fistulae (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=40, Recruiting, Sponsor: University of Zurich
- | doxycycline / Generic mfg.
Enrollment closed: Evaluation of Local Doxycycline in Smokers With Chronic Periodontitis (clinicaltrials.gov) - Oct 26, 2017
P2, N=40, Active, not recruiting, Sponsor: University of Campinas, Brazil
Trial primary completion date: Sep 2017 --> Sep 2018 Recruiting --> Active, not recruiting
- | doxycycline / Generic mfg.
Enrollment open: Duration of Doxycycline Treatment in EM Patients (clinicaltrials.gov) - Oct 25, 2017
P=N/A, N=300, Recruiting, Sponsor: University Medical Centre Ljubljana
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | doxycycline / Generic mfg.
Enrollment closed: ADORE: A Trial of Doxycycline in Renal Disease (clinicaltrials.gov) - Oct 9, 2017
P1, N=11, Active, not recruiting, Sponsor: University of California, San Francisco
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | Betadine (povidone iodine) / Egis
Enrollment open, Trial initiation date, Trial primary completion date: CARRIER: S. Aureus Decolonization in HPN Patients. (clinicaltrials.gov) - Oct 2, 2017
P=N/A, N=138, Recruiting, Sponsor: Radboud University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Aug 2017 --> Jan 2018 | Trial primary completion date: Aug 2020 --> Jan 2021
- | Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Enrollment open, Trial initiation date, Trial primary completion date: CTCL Directed Therapy (clinicaltrials.gov) - Oct 2, 2017
P, N=8, Recruiting, Sponsor: James J. Peters Veterans Affairs Medical Center
Not yet recruiting --> Recruiting | Initiation date: Aug 2017 --> Jan 2018 | Trial primary completion date: Aug 2020 --> Jan 2021 Not yet recruiting --> Recruiting | Initiation date: May 2017 --> Oct 2017 | Trial primary completion date: Mar 2018 --> Jun 2018
- | doxycycline / Generic mfg.
Trial primary completion date: Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline (SPARED) Trial (clinicaltrials.gov) - Sep 26, 2017
P=N/A, N=300, Recruiting, Sponsor: University of Rochester
Not yet recruiting --> Recruiting | Initiation date: May 2017 --> Oct 2017 | Trial primary completion date: Mar 2018 --> Jun 2018 Trial primary completion date: Oct 2017 --> Oct 2018
- | doxycycline / Generic mfg., amoxicillin / Generic mfg.
Trial primary completion date: Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis (clinicaltrials.gov) - Sep 20, 2017
P4, N=20, Recruiting, Sponsor: Prof. Arie Levine
Trial primary completion date: Oct 2017 --> Oct 2018 Trial primary completion date: Apr 2017 --> Dec 2018
- | doxycycline / Generic mfg.
Trial initiation date: Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma (clinicaltrials.gov) - Sep 13, 2017
P2, N=20, Not yet recruiting, Sponsor: Rochester General Hospital
Trial primary completion date: Apr 2017 --> Dec 2018 Initiation date: Aug 2017 --> Nov 2017
- | doxycycline / Generic mfg.
Enrollment change: Topical NanoDox® for Atopic Dermatitis (clinicaltrials.gov) - Sep 8, 2017
P2, N=20, Recruiting, Sponsor: University of Florida
Initiation date: Aug 2017 --> Nov 2017 N=15 --> 20
- | doxycycline / Generic mfg., azithromycin / Generic mfg.
Trial completion, Trial primary completion date: A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions (clinicaltrials.gov) - Aug 30, 2017
P=N/A, N=180, Completed, Sponsor: Medstar Health Research Institute
N=15 --> 20 Recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jul 2017
- |||| doxycycline / Generic mfg., ivermectin topical / Generic mfg.
Enrollment open: ANSWER: Oracea Soolantra Association in Participants With Severe Rosacea (clinicaltrials.gov) - Aug 28, 2017
P4, N=270, Recruiting, Sponsor: Galderma
Recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jul 2017 Not yet recruiting --> Recruiting
- | Trial primary completion date: Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) (clinicaltrials.gov) - Aug 23, 2017
P2, N=40, Active, not recruiting, Sponsor: Johns Hopkins University
Not yet recruiting --> Recruiting Trial primary completion date: Mar 2017 --> Dec 2017
- | Enrollment closed, Enrollment change, Trial primary completion date: Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization (clinicaltrials.gov) - Aug 22, 2017
P=N/A, N=100, Active, not recruiting, Sponsor: Horizon Health Network
Trial primary completion date: Mar 2017 --> Dec 2017 Recruiting --> Active, not recruiting | N=200 --> 100 | Trial primary completion date: Dec 2016 --> Dec 2017
- | metformin / Generic mfg., doxycycline / Generic mfg.
Enrollment open, Surgery: Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery (clinicaltrials.gov) - Aug 17, 2017
P2, N=72, Recruiting, Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Recruiting --> Active, not recruiting | N=200 --> 100 | Trial primary completion date: Dec 2016 --> Dec 2017 Suspended --> Recruiting
- | trimethoprim/sulfamethoxazole / Generic mfg., doxycycline / Generic mfg.
Enrollment open: CleanUp-IPF: CleanUP IPF for the Pulmonary Trials Cooperative (clinicaltrials.gov) - Aug 10, 2017
P3, N=500, Recruiting, Sponsor: Weill Medical College of Cornell University
Suspended --> Recruiting Not yet recruiting --> Recruiting
- | doxycycline / Generic mfg.
Trial completion: Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients (clinicaltrials.gov) - Jul 26, 2017
P3, N=222, Completed, Sponsor: Imperial College London
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | doxycycline / Generic mfg.
Trial primary completion date: LeDoxy-India: A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India (clinicaltrials.gov) - Jul 21, 2017
P3, N=250, Not yet recruiting, Sponsor: The Task Force for Global Health
Active, not recruiting --> Completed Trial primary completion date: Jun 2019 --> Dec 2019
- | doxycycline / Generic mfg.
Trial primary completion date: LeDoxy-SL: A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka (clinicaltrials.gov) - Jul 21, 2017
P3, N=250, Not yet recruiting, Sponsor: The Task Force for Global Health
Trial primary completion date: Jun 2019 --> Dec 2019 Trial primary completion date: Jun 2019 --> Dec 2019
- | doxycycline / Generic mfg.
Trial primary completion date: LeDoxy-Mali: A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali (clinicaltrials.gov) - Jul 21, 2017
P3, N=250, Not yet recruiting, Sponsor: The Task Force for Global Health
Trial primary completion date: Jun 2019 --> Dec 2019 Trial primary completion date: Jun 2019 --> Dec 2019
- | Trial completion, Trial initiation date: Treating Periodontal Infection: Effects on Glycemic (clinicaltrials.gov) - Jul 19, 2017
P2, N=46, Completed, Sponsor: University of Michigan
Trial primary completion date: Jun 2019 --> Dec 2019 Active, not recruiting --> Completed | Initiation date: Apr 2001 --> Oct 2001
- | doxycycline / Generic mfg.
New trial, Combination therapy: Re-evaluation of Some Old Rheumatoid Arthritis Therapy: A Randomized Controlled Trial (clinicaltrials.gov) - Jun 21, 2017
P=N/A, N=120, Not yet recruiting, Sponsor: Assiut University
- | doxycycline / Generic mfg.
Trial completion, Enrollment change: Safety and Effect of Doxycycline in Patients With Amyloidosis (clinicaltrials.gov) - Jun 8, 2017
P2, N=25, Completed, Sponsor: Boston University
Active, not recruiting --> Completed | Initiation date: Apr 2001 --> Oct 2001 Active, not recruiting --> Completed | N=60 --> 25
- | Betadine (povidone iodine) / Egis
New trial: CARRIER: S. Aureus Decolonization in HPN Patients. (clinicaltrials.gov) - Jun 1, 2017
P=N/A, N=138, Not yet recruiting, Sponsor: Radboud University
- |||||| atorvastatin / Generic mfg., mebendazole / Generic mfg., doxycycline / Generic mfg.
Enrollment open, Phase classification, Enrollment change, Trial initiation date, Trial primary completion date, Real-world evidence, Real-world: METRICS: Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer (clinicaltrials.gov) - May 30, 2017
P3, N=207, Recruiting, Sponsor: Health Clinics Limited
Active, not recruiting --> Completed | N=60 --> 25 Suspended --> Recruiting | Phase classification: PN/A --> P3 | N=2000 --> 207 | Initiation date: Oct 2016 --> May 2017 | Trial primary completion date: Oct 2021 --> May 2022
- | doxycycline / Generic mfg., azithromycin / Generic mfg.
New P4 trial: Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction (clinicaltrials.gov) - May 22, 2017
P4, N=40, Not yet recruiting, Sponsor: Medical University of Vienna
- | doxycycline / Generic mfg.
Enrollment open: Topical NanoDox® for Atopic Dermatitis (clinicaltrials.gov) - May 19, 2017
P2, N=15, Recruiting, Sponsor: University of Florida
Suspended --> Recruiting | Phase classification: PN/A --> P3 | N=2000 --> 207 | Initiation date: Oct 2016 --> May 2017 | Trial primary completion date: Oct 2021 --> May 2022 Not yet recruiting --> Recruiting
- | doxycycline / Generic mfg.
New trial: Duration of Doxycycline Treatment in EM Patients (clinicaltrials.gov) - May 15, 2017
P=N/A, N=300, Not yet recruiting, Sponsor: University Medical Centre Ljubljana
- | doxycycline / Generic mfg.
Enrollment change: ADORE: A Trial of Doxycycline in Renal Disease (clinicaltrials.gov) - May 10, 2017
P1, N=12, Recruiting, Sponsor: University of California, San Francisco
Not yet recruiting --> Recruiting N=20 --> 12
- | ceftriaxone / Generic mfg., doxycycline / Generic mfg.
Enrollment open, Trial primary completion date: Antibiotic Treatment of Multiple Erythema Migrans (clinicaltrials.gov) - May 5, 2017
P=N/A, N=500, Recruiting, Sponsor: University Medical Centre Ljubljana
N=20 --> 12 Active, not recruiting --> Recruiting | Trial primary completion date: Oct 2016 --> Oct 2017